Cleared Traditional

LAPAROSCOPIC NEEDLE HOLDER (K924196) - FDA 510(k) Clearance

Class I Gastroenterology & Urology device.

K924196 · Nusurg, Inc. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1993
Decision
309d
Days
Class 1
Risk

K924196 is an FDA 510(k) clearance for the LAPAROSCOPIC NEEDLE HOLDER. Classified as Holder, Needle, Gastroenterologic (product code FHQ), Class I - General Controls.

Submitted by Nusurg, Inc. (Cincinnati, US). The FDA issued a Cleared decision on June 25, 1993 after a review of 309 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4730 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Nusurg, Inc. devices

Submission Details

510(k) Number K924196 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 1992
Decision Date June 25, 1993
Days to Decision 309 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
179d slower than avg
Panel avg: 130d · This submission: 309d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code FHQ Holder, Needle, Gastroenterologic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 876.4730
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.